TG Therapeutics, Inc. (TGTX) is listed on NASDAQ in Pharmaceutical Stocks. It is $53.91, -3.26%, with a $8.3B market cap. RSI is 53.0, neutral. The latest reported quarter missed estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 53.0 Neutral
Market Cap $8.3B
Volume 884.6K
Fundamentals — 10-Q Q2 2026
Revenue $445.3M
Net Income $27.6M
EPS $0.17
Gross Margin 83.2%
Operating Margin 12.7%
Net Margin 6.2%
Debt / Equity 1.2x
P/E Ratio 317.1x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Echelard Yann | Director | Sell | 5,000 | $32.57 | $162,850 | 2025 Nov 24 |
| Lonial Sagar | Director | Sell | 20,852 | $32.24 | $672,268 | 2025 Sep 11 |
| Echelard Yann | Director | Sell | 10,000 | $36.94 | $369,400 | 2025 Jun 13 |
| Power Sean A | CFO | Sell | 21,358 | $29.46 | $629,297 | 2025 Jan 6 |
| Lonial Sagar | Director | Sell | 5,000 | $30.44 | $152,200 | 2024 Nov 11 |
| Charney Laurence N | Director | Sell | 25,000 | $30.20 | $755,000 | 2024 Nov 11 |
| Echelard Yann | Director | Sell | 20,000 | $24.48 | $489,600 | 2024 Nov 5 |
| Lonial Sagar | Director | Sell | 25,933 | $16.69 | $432,889 | 2024 Jun 20 |
| Lonial Sagar | Director | Sell | 5,000 | $15.94 | $79,700 | 2024 Mar 13 |
| Charney Laurence N | Director | Sell | 22,000 | $15.97 | $351,340 | 2024 Mar 12 |
| Charney Laurence N | Director | Sell | 17,500 | $19.03 | $333,025 | 2024 Jan 5 |
| Power Sean A | CFO | Sell | 47,867 | $16.91 | $809,431 | 2024 Jan 3 |
| Weiss Michael S | CEO and President | Buy | 100,000 | $10.13 | $1.0M | 2023 Aug 11 |
| Lonial Sagar | Director | Sell | 34,854 | $23.37 | $814,538 | 2023 Jun 23 |
| Power Sean A | Chief Financial Officer | Sell | 73,647 | $26.70 | $2.0M | 2023 Jun 2 |
| Echelard Yann | Director | Buy | 9,000 | $10.64 | $95,760 | 2023 Jan 6 |
| Charney Laurence N | Director | Sell | 30,000 | $11.10 | $333,000 | 2023 Jan 4 |
| Power Sean A | CFO, Secretary and Treasurer | Sell | 84,965 | $19.10 | $1.6M | 2022 Jan 5 |
| Weiss Michael S | CEO and President | Sell | 68,220 | $18.80 | $1.3M | 2022 Jan 5 |
| Echelard Yann | Director | Sell | 30,000 | $40.05 | $1.2M | 2020 Dec 10 |
Other Pharmaceutical Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $1,173.34 | 46.3 | $1.1T |
| | $268.01 | 58.6 | $645.9B |
| | $148.31 | 64.1 | $365.9B |
| | $105.79 | 46.8 | $5.9B |
| | $13.71 | 51.0 | $10.9B |
| | $33.21 | 63.0 | -- |
| | $34.78 | 68.0 | $3.9B |
| | $65.68 | 62.9 | $6.2B |
Take TGTX further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put TGTX in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when TG Therapeutics, Inc. next reports.
Set alerts on TGTX
Get notified when TG Therapeutics, Inc. hits your price targets or technical conditions are met.
Get Started Free